BG Stock Analysis: Bunge Global | NYSE
Farm Products | NYSE, USA | Market Cap: 19.788m USD | 12M Return: 10.8% | CH1300646267 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 166M
EPS Trend: -91.8%
Qual. Beats: 0
Rev. Trend: 59.7%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bunge Global SA is a global agribusiness and food company founded in 1818 and headquartered in Chesterfield, Missouri. The company operates through four business segments: Soybean Processing and Refining, Softseed Processing and Refining, Other Oilseeds Processing and Refining, and Grain Merchandising and Milling. These segments collectively cover the full agricultural value chain, including the purchase, storage, transportation, processing, refining, distribution, and marketing of soybeans, softseeds, specialty oilseeds, and grain commodities such as corn, wheat, barley, cotton, pulses, and sugar.
The company also produces and distributes biodiesel and fertilizer, providing products to the food, animal feed, and biofuel industries. Its grain segment includes milling operations for wheat and sugar, along with related services such as ocean freight and financial services.
As a major player in the agricultural products and services sub-industry, Bunge benefits from its integration across the global commodity supply chain, which provides scale advantages in sourcing and logistics. The agricultural products sector is typically influenced by global commodity prices, weather patterns, crop yields, and international trade flows, making it sensitive to macroeconomic and geopolitical conditions.
- Soybean crush margins expand on robust biofuel oil demand
- Bunge-Viterra merger completion reshapes global grain competition
- South American harvest volumes drive origination and merchandising segment results
| Net Income: 1.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 0.20 > 1.0 |
| NWC/Revenue: 10.33% < 20% (prev 21.75%; Δ -11.42% < -1%) |
| CFO/TA 0.02 > 3% & CFO 1.07b > Net Income 1.01b |
| Net Debt (17.8b) to EBITDA (3.12b): 5.72 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.3m) vs 12m ago 44.06% < -2% |
| Gross Margin: 4.92% > 18% (prev 6.27%; Δ -1.34% > 0.5%) |
| Asset Turnover: 235.6% > 50% (prev 163.3%; Δ 72.37% > 0%) |
| Interest Coverage Ratio: 2.71 > 6 (EBIT TTM 2.16b / Interest Expense TTM 796.0m) |
| A: 0.20 (Total Current Assets 26.2b - Total Current Liabilities 16.7b) / Total Assets 46.8b |
| B: 0.29 (Retained Earnings 13.3b / Total Assets 46.8b) |
| C: 0.06 (EBIT TTM 2.16b / Avg Total Assets 39.0b) |
| D: 0.54 (Book Value of Equity 16.0b / Total Liabilities 29.4b) |
| Altman-Z'' = 3.20 = A |
| DSRI: 0.78 (Receivables 3.93b/2.79b, Revenue 91.8b/50.9b) |
| GMI: 1.27 (GM 6.27% / 4.92%) |
| AQI: 1.60 (AQ_t 0.15 / AQ_t-1 0.09) |
| SGI: 1.81 (Revenue 91.8b / 50.9b) |
| TATA: -0.00 (NI 1.01b - CFO 1.07b) / TA 46.8b) |
| Beneish M = -2.03 (Cap -4..+1) = BB |
As of October 23, 2026, the stock is trading at USD 103.15 with a total of 1,331,903 shares traded. Over the past week, the price has changed by -3.61%, over one month by -6.23%, over three months by -16.21% and over the past year by +10.80%.
Current recommended Stop Loss: 98.80 (which is 4.2% or 1.3 ATR below the current price).
Bunge Global has received a consensus analysts rating of 4.44. Therefore, it is recommended to buy BG.
- StrongBuy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 140.6 | 36.3% |
P/E Trailing = 20.5179
P/E Forward = 9.5877
P/S = 0.2155
P/B = 1.4368
P/EG = 1.7053
Revenue TTM = 91.8b USD
EBIT TTM = 2.16b USD
EBITDA TTM = 3.12b USD
Long Term Debt = 9.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.29b USD (from shortTermDebt, last quarter)
Debt = 18.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.60b
Net Debt = 17.8b USD (calculated: Debt 18.4b - CCE 593.0m)
Enterprise Value = 37.6b USD (19.8b + Debt 18.4b - CCE 593.0m)
Interest Coverage Ratio = 2.71 (Ebit TTM 2.16b / Interest Expense TTM 796.0m)
EV/FCF = -52.89x (Enterprise Value 37.6b / FCF TTM -711.0m)
FCF Yield = -1.89% (FCF TTM -711.0m / Enterprise Value 37.6b)
FCF Margin = -0.77% (FCF TTM -711.0m / Revenue TTM 91.8b)
Net Margin = 1.10% (Net Income TTM 1.01b / Revenue TTM 91.8b)
Gross Margin = 4.92% ((Revenue TTM 91.8b - Cost of Revenue TTM 87.3b) / Revenue TTM)
Gross Margin QoQ = 6.99% (prev 3.50%)
Tobins Q-Ratio = 0.80 (Enterprise Value 37.6b / Total Assets 46.8b)
Interest Expense / Debt = 4.32% (Interest Expense 796.0m / Debt 18.4b)
Taxrate = 22.50% (306.0m / 1.36b)
NOPAT = 1.67b (EBIT 2.16b * (1 - 22.50%))
Current Ratio = 1.57 (Total Current Assets 26.2b / Total Current Liabilities 16.7b)
Debt / Equity = 1.15 (Debt 18.4b / totalStockholderEquity, last quarter 16.0b)
Debt / EBITDA = 5.72 (Net Debt 17.8b / EBITDA 3.12b)
Debt / FCF = -25.06 (negative FCF - burning cash) (Net Debt 17.8b / FCF TTM -711.0m)
Total Stockholder Equity = 15.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.58% (Net Income 1.01b / Total Assets 46.8b)
RoE = 6.33% (Net Income TTM 1.01b / Total Stockholder Equity 15.9b)
RoCE = 8.51% (EBIT 2.16b / Capital Employed (Equity 15.9b + L.T.Debt 9.43b))
RoIC = 4.67% (NOPAT 1.67b / Invested Capital 35.7b)
WACC = 4.53% (E(19.8b)/V(38.2b) * Re(5.63%) + D(18.4b)/V(38.2b) * Rd(4.32%) * (1-Tc(0.23)))
Discount Rate = 5.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.40 | Cagr: 14.02%
[DCF] Fair Price = unknown (Cash Flow -711.0m)
EPS Correlation: -91.80 | EPS CAGR: -22.73% | SUE: -0.08 | # QB: 0
Revenue Correlation: 59.66 | Revenue CAGR: 12.93% | SUE: 1.52 | # QB: 1
EPS current Quarter (2026-09-30): EPS=2.42 | Chg30d=-2.13% | Revisions=+0% | Analysts=7
EPS current Year (2026-12-31): EPS=9.51 | Chg30d=-1.28% | Revisions=-40% | GrowthEPS=+25.7% | GrowthRev=+30.4%
EPS next Year (2027-12-31): EPS=11.23 | Chg30d=-0.99% | Revisions=-40% | GrowthEPS=+18.0% | GrowthRev=+2.7%
[Analyst] Revisions Ratio: -44% (up=1, down=5)